• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back
tolbutamid
first generation sulfonylurea
mech: close K+ channel in beta cell membrane so that cell depolarizes, releasing more insulin

clincal use: useful in type 2 DM

toxicity: disulfram-like effects
chlorpropamide
first generation sulfonylurea
mech: close K+ channel in beta cell membrane so that cell depolarizes, releasing more insulin

clincal use: useful in type 2 DM

toxicity: disulfram-like effects
glyburide
2nd generation sulfonylurea

mech: close K+ channels, beta cells depolarize, releasing more insulin

use: type 2 DM

side effects: hypoglycemia
glimepiride
2nd generation sulfonylurea

mech: close K+ channels, beta cells depolarize, releasing more insulin

use: type 2 DM

side effects: hypoglycemia
glipizide
2nd generation sulfonylurea

mech: close K+ channels, beta cells depolarize, releasing more insulin

use: type 2 DM

side effects: hypoglycemia
metformin
biguanide

exact mechanism unkown - decrease glconeogenesis, increase glycolysis, lower glucose levels (insulin sensitizer)

use - type 2 DM

toxicity: lactic acidosis
glitazones
rosiglitazone, pioglitazone

mech: increase target cell response to insulin by regulating adipokines

use: monotherapy or combined for type 2 DM

toxicity: wieght gain, edema, hepato and cardio toxic perhaps
acarbose
alpha-glucosidase inhibitor

mechanism - delayed sugar hydrolysis/glucose absorption at brush border

use: T2DM

side effects: GI
miglitol
alpha-glucosidase inhibitor
delays sugar hydrolysis and glucose uptake at brush border

Use: type 2 DM

side effects: GI
pramlintide
mimics amylin, which lower glucagon and sensities insulin effects

use: t2dm, type 1 also?

side effects: hypoglycemia, nausea, diarrhea
exenatide
raises insulin, lowers glucagon release

use: type 2

side effects: N/V, maybe pancreatitis
orlistat
inhibits pancreatic lipase

use: obesity

side effects: steatorhaa, GI discomfort, reduced absorption of ADEK
sibutramine
mechanism: sympathomimetic serotonin, NE reuptake inhibitor
use: obesity

toxicity: htn, tachycardia
propylthiouraicl, methimazole
mechanism: inhibit thyroid hormone synthesis, decreased peripheral conversion T4 to T3 (propylthiouracil)

use: hyperthyroid

toxicity: rare agranulocytosis, aplastic anemia. rash.
GH
GH deficiency, turners
somatostatin (octreotide)
acromegaly, carcinoid syndrome, gastrinoma, glucagonoma

inhibits GH, TSH and all the gastropeptides (VIP, gastrin etc)
oxytocin
stimulates labor and ocntraction, milk let-down
controls uterine hemorrhage
ADH (desmopressin)
central DI
levothyroxine
hypothyroid, myxedema

toxicity: tachycardia, heat intolerance, tremors, arrhythima
demeclocycline
ADH antagonist
used for SIADH

toxicity: photosensitivity; abnormalities of bone and teeth